Leann Mclaughlin is a Uro-Oncology Clinical Nurse Specialist who helps guide men through diagnosis, treatment decisions and ongoing prostate cancer care. Alongside her clinical work, she advises Prostate Scotland and contributes to NICE guidelines on prostate cancer diagnosis and management. During our conversation for Movember, she shared insights into common misconceptions, the importance of early detection and the questions patients ask most often. 


How do you support patients through the diagnosis process? 

I review referrals from GPs, arrange investigations such as MRI scans, discuss results with patients and perform prostate biopsies when needed. This allows me to build a relationship with each patient from the beginning. 

One of the most important aspects of the role is continuity. Patients know they have someone they can contact if they have questions or concerns, and I can help explain information in clear, understandable language.  

What are the most common misconceptions about prostate cancer? 

The biggest misconception is that prostate cancer always causes symptoms. 

Many men are shocked when they’re diagnosed because they felt completely well. Prostate cancer can be a silent disease, particularly in its earlier stages. 

Another misconception is that prostate cancer is always a “good cancer” to have. While many prostate cancers are highly treatable, some are aggressive or may already have spread, so every diagnosis needs to be taken seriously.   

Why should men pay attention even if they feel healthy? 

Because you do not need symptoms to have prostate cancer. 

Many men who come to us after a PSA test have no urinary symptoms at all. That’s why it’s important to have conversations with your GP about your risk, particularly if you have a family history or belong to a higher-risk group.  

How does PSA testing work? 

PSA stands for prostate-specific antigen, a protein released by the prostate. A raised PSA level does not necessarily mean prostate cancer. PSA can also increase due to an enlarged prostate, inflammation or infection. 

Importantly, a PSA test is simply a blood test. Many men still worry that asking about prostate cancer automatically means undergoing a physical examination, but that’s often one of the misconceptions that prevents men from getting checked. 

If PSA levels are elevated, further investigations such as an MRI scan can help determine whether cancer may be present. 

What concerns patients most? 

Often, patients aren’t asking detailed questions about staging or pathology. They’re asking:  

“Can I still work?”, “How will this affect my relationship?”, “Will I be there for my family?”, or “Will my life ever get back to normal?” 

Quality of life is often the biggest concern.  

How do you help patients worried about sexual side effects? 

These conversations can be difficult, but they’re incredibly important. 

We reassure patients that support is available and that many treatment options exist to help with erectile dysfunction and other side effects. We also talk about the emotional impact of treatment and encourage honest conversations with partners. 

One of the things I often tell patients is that intimacy doesn’t have to look exactly the same as it did before treatment. There are many ways to maintain closeness and intimacy in a relationship, and it’s important not to define yourself solely by sexual function. 

I also remind men that the people who love them are not with them because of an erection. There are many ways to maintain closeness with a partner, and the people who love you don’t stop loving you because you’ve had prostate cancer treatment. 

Partners are often far more understanding than patients expect, and having open conversations can help reduce a lot of the anxiety and fear surrounding treatment. 

For many men, having a nurse specialist they feel comfortable speaking to makes a huge difference. Sometimes they need practical information about side effects and recovery, but just as often they need reassurance that they’re not facing these challenges alone. 

Which men are at higher risk for prostate cancer? 

Age is one of the biggest risk factors for prostate cancer, with the risk increasing as men get older. 

Black men are also at significantly higher risk of developing prostate cancer and should consider discussing testing earlier. Men with a father or brother who has had prostate cancer are at increased risk as well. 

That’s why it’s important to understand your personal risk factors and have a conversation with your GP if you have any concerns. 

My advice is simple: don’t wait for symptoms. Many men diagnosed with prostate cancer feel completely well. If you’re concerned, speak to your GP. 

How do patients choose between treatment options? 

Every patient’s situation is different. The treatment options available will depend on factors such as the stage of the cancer, how aggressive it appears to be, and the patient’s overall health. 

My role is to help patients understand their options and support them in making an informed decision. We talk through the potential benefits and side effects of each treatment, whether that’s surgery, radiotherapy, hormone therapy, or, in some cases, active surveillance. 

What matters most to one patient may be very different for another. Some patients are caring for a loved one, some want to get back to work as quickly as possible, and others are most concerned about how treatment may affect their quality of life. 

I always encourage patients to think about what’s important to them personally, ask questions, and take the time they need to consider their options. The decision should be based not only on the cancer itself, but also on the individual’s circumstances and priorities. 

After supporting so many men, what’s one thing you wish everyone knew about prostate cancer? 

That prostate cancer can be a silent disease. 

You don’t need symptoms to start a conversation. If you’re concerned, speak to your GP and ask about your risk. Early conversations can make a real difference. 

 

November Talks

Read interviews, patient journeys, and expert perspectives from November Talks

Continue reading